Clinical-stage biotechnology company.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | TODD STRATEGY GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| TODD STRATEGY GROUP | 5 | — |
| Issue | Activities |
|---|---|
| Medical/Disease Research/Clinical Labs | 5 |